CD Projekt S.A. - OTGLY

OTGLY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
OTGLY	2.2	-1.5	-6.2	-12.1	12.4	40.8	-10.9	-43.2	-43.2	-43.2
S&P 500	-0.6	-0.5	2.3	7.3	12.1	32.1	27.0	90.7	191.4	33587.3

Compare OTGLY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	OTGLY
name	CD Projekt S.A.
price	9.80
changes percentage	2.19
change	0.21
day low	9.70
day high	10.25
year high	12.01
year low	6.10
market cap	3916491600
price avg 50	10.51
price avg 200	8.95
exchange	PNK
volume	920
avg volume	11343
open	10.25
previous close	9.59
eps	0.34
pe	28.82
earnings announcement	2024-11-26T10:59:00.000+0000
shares outstanding	399642000
timestamp	2024-11-14 20:59:59

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 76.7%

Overall Quarterly Financial Health: 44.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0
revenue	1230199000	952576000	29.14
gross profit	849632000	708602000	19.90
gross profit ratio	0.69	0.74	-7.16
research and development expenses	0	103604000	-100.00
operating expenses	380592000	298535000	27.49
interest income	48007000	43337000	10.78
interest expense	-1452000	1347000	-207.80
ebitda	553325000	408360000	35.50
ebitdaratio	0.45	0.6	-25.53
operating income	469040000	377347000	24.30
operating income ratio	0.38	0.4	-3.75
net income	481105000	347093000	38.61
net income ratio	0.39	0.36	7.33
eps	4.8	3.45	39.13

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,230 million in 2023 from 953 million in 2022 representing a change of 29.14%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 104 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 381 million in 2023 from 299 million in 2022 representing a change of 27.49%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 850 million in 2023 from 709 million in 2022 representing a change of 19.9%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 553 million in 2023 from 408 million in 2022 representing a change of 35.5%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 469 million in 2023 from 377 million in 2022 representing a change of 24.3%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 481 million in 2023 from 347 million in 2022 representing a change of 38.61%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.8 in 2023 from 4.8 in 2022 representing a change of 39.13%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0
revenue	198027000	226785000	-12.68
gross profit	135233000	164732000	-17.91
gross profit ratio	0.68	0.73	-5.99
research and development expenses	25275000	20643000	22.44
operating expenses	76306000	84607000	-9.81
interest income	17934000	16386000	9.45
interest expense	305000	414000	-26.33
ebitda	107748000	127554000	-15.53
ebitdaratio	0.54	0.56	-3.24
operating income	58927000	81296000	-27.52
operating income ratio	0.3	0.36	-16.99
net income	69944000	100062000	-30.10
net income ratio	0.35	0.44	-19.95
eps	0.7	0.25	180.00

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 198 million in 2024Q2 from 227 million in 2024Q1 representing a change of -12.68%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 135 million in 2024Q2 from 165 million in 2024Q1 representing a change of -17.91%. This indicates a sales profitability decline, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 108 million in 2024Q2 from 128 million in 2024Q1 representing a change of -15.53%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 59 million in 2024Q2 from 81 million in 2024Q1 representing a change of -27.52%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 25 million in 2024Q2 from 21 million in 2024Q1 representing a change of 22.44%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 76 million in 2024Q2 from 85 million in 2024Q1 representing a change of -9.81%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 70 million in 2024Q2 from 100 million in 2024Q1 representing a change of -30.1%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.7 in 2024Q2 from 0.7 in 2024Q1 representing a change of 180.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	2613438000	2274124000	14.92
total liabilities	209948000	240720000	-12.78
total equity	2403490000	2033404000	18.20
cash and cash equivalents	178054000	277827000	-35.91
short term investments	700924000	616845000	13.63
long term investments	-206922000	-367801000	43.74
total current assets	1162815000	1154146000	0.75
total non current assets	1450623000	1119978000	29.52
total current liabilities	171174000	204534000	-16.31
total non current liabilities	38774000	36186000	7.15
common stock	99911000	100771000	-0.85
retained earnings	450308000	344442000	30.74
total debt	20038000	28461000	-29.59

Overall Score of Annual Balance Sheet

0.8 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,613 million in 2023 from 2,274 million in 2022 representing a change of 14.92%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 210 million in 2023 from 241 million in 2022 representing a change of -12.78%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 2,403 million in 2023 from 2,033 million in 2022 representing a change of 18.2%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 701 million in 2023 from 617 million in 2022 representing a change of 13.63%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,163 million in 2023 from 1,154 million in 2022 representing a change of 0.75%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 171 million in 2023 from 205 million in 2022 representing a change of -16.31%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 450 million in 2023 from 344 million in 2022 representing a change of 30.74%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 20 million in 2023 from 28 million in 2022 representing a change of -29.59%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 178 million in 2023 from 278 million in 2022 representing a change of -35.91%. This indicates a decrease in available liquid assets.

  Common Stock: Common Stock decreased to 100 in 2023 from 101 in 2022 representing a change of -0.85%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	2660007000	2723219000	-2.32
total liabilities	175653000	216134000	-18.73
total equity	2484354000	2507085000	-0.91
cash and cash equivalents	148980000	123762000	20.38
short term investments	340845000	923006000	-63.07
long term investments	464841000	-467578000	199.41
total current assets	1134848000	1251531000	-9.32
total non current assets	1525159000	1471688000	3.63
total current liabilities	139763000	180320000	-22.49
total non current liabilities	35890000	35814000	0.21
common stock	99911000	99911000	0.00
retained earnings	165706000	550103000	-69.88
total debt	18628000	17912000	4.00

Overall Score of Quarterly Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 2,660 million in 2024Q2 from 2,723 million in 2024Q1 representing a change of -2.32%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 2,484 million in 2024Q2 from 2,507 million in 2024Q1 representing a change of -0.91%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 341 million in 2024Q2 from 923 million in 2024Q1 representing a change of -63.07%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,135 million in 2024Q2 from 1,252 million in 2024Q1 representing a change of -9.32%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 166 million in 2024Q2 from 550 million in 2024Q1 representing a change of -69.88%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 19 million in 2024Q2 from 18 million in 2024Q1 representing a change of 4.0%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 176 million in 2024Q2 from 216 million in 2024Q1 representing a change of -18.73%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 149 million in 2024Q2 from 124 million in 2024Q1 representing a change of 20.38%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 140 million in 2024Q2 from 180 million in 2024Q1 representing a change of -22.49%. This indicates a lower short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-99773000	-133759000	25.41
operating cash flow	610881000	406031000	50.45
free cash flow	280066000	149926000	86.80
capital expenditure	-330815000	-256105000	-29.17
depreciation and amortization	13970000	117432000	-88.10
deferred income tax	-16681000	-4276000	-290.11
stock based compensation	0	4276000	-100.00
accounts payables	60033000	-19613000	406.09
inventory	9125000	3185000	186.50
acquisitions net	-9480000	-35011000	72.92
investments in property plant and equipment	-330815000	-256105000	-29.17
net cash used for investing activites	-607345000	-335607000	-80.97
debt repayment	0	0	NaN
common stock issued	0	822000	-100.00
common stock repurchased	0	-99993000	100.00
dividends paid	-99911000	-100739000	0.82
net cash used provided by financing activities	-103309000	-204183000	49.40
cash at end of period	178054000	277827000	-35.91
accounts receivables	-60033000	-44052000	-36.28
cash at beginning of period	277827000	411586000	-32.50

Overall Score of Annual Cashflow Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -100 million in 2023 from -134 million in 2022 representing a change of 25.41%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 611 million in 2023 from 406 million in 2022 representing a change of 50.45%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 280 million in 2023 from 150 million in 2022 representing a change of 86.8%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -331 million in 2023 from -256 million in 2022 representing a change of -29.17%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 4 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -60 million in 2023 from -44 million in 2022 representing a change of -36.28%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -100 million in 2023 from -101 million in 2022 representing a change of 0.82%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Accounts Payables: The absolute value of Accounts Payables increased to 60 million in 2023 from 20 million in 2022 representing a change of 406.09%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	69934000	180995000	-61.36
free cash flow	-10363000	117211000	-108.84
capital expenditure	-80297000	-63784000	-25.89
depreciation and amortization	29867000	29950000	-0.28
deferred income tax	0	0	NaN
stock based compensation	0	4032000	-100.00
accounts receivables	14533000	92246000	-84.25
accounts payables	-11151000	-5857000	-90.39
inventory	-59000	316000	-118.67
acquisitions net	0	-3168000	100.00
investments in property plant and equipment	-23397000	-63784000	63.32
net cash used for investing activites	56119000	-234148000	123.97
debt repayment	-730000	-932000	21.67
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-99911000	0	NaN
net cash used provided by financing activities	-100835000	-1139000	-8,752.94
net change in cash	25218000	-54292000	146.45
cash at end of period	148980000	123762000	20.38
cash at beginning of period	123762000	178054000	-30.49

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 25 million in 2024Q2 from -54 million in 2024Q1 representing a change of 146.45%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -80 million in 2024Q2 from -64 million in 2024Q1 representing a change of -25.89%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q2 from 4 million in 2024Q1 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to 15 million in 2024Q2 from 92 million in 2024Q1 representing a change of -84.25%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 70 million in 2024Q2 from 181 million in 2024Q1 representing a change of -61.36%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -10 million in 2024Q2 from 117 million in 2024Q1 representing a change of -108.84%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 11 million in 2024Q2 from 6 million in 2024Q1 representing a change of -90.39%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -100 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q3 2022 Earnings call transcript
Q2 2022 Earnings call transcript
Q1 2022 Earnings call transcript
Q3 2021 Earnings call transcript
Q2 2021 Earnings call transcript
Q1 2021 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	12.27	9.46	29.75
net income per share	4.8	3.45	39.26
operating cash flow per share	6.09	4.03	51.16
free cash flow per share	2.79	1.49	87.68
cash per share	8.77	8.88	-1.29
book value per share	23.97	20.18	18.76
tangible book value per share	22.71	14.24	59.47
shareholders equity per share	23.97	20.18	18.76
interest debt per share	-0.01	-0.25	94.22
market cap	2834063386.0	3263704180.35	-13.16
enterprise value	2676047386.0	3014338180.35	-11.22
pe ratio	5.89	9.4	-37.35
price to sales ratio	2.3	3.43	-32.76
pocfratio	4.64	8.04	-42.28
pfcf ratio	10.12	21.77	-53.51
pb ratio	1.18	1.61	-26.54
ptb ratio	1.18	1.61	-26.54
ev to sales	2.18	3.16	-31.26
enterprise value over ebitda	4.84	7.38	-34.48
ev to operating cash flow	4.38	7.42	-40.99
ev to free cash flow	9.56	20.11	-52.48
earnings yield	0.17	0.11	59.62
free cash flow yield	0.1	0.05	115.12
debt to equity	0	-0.01	100.00
debt to assets	0	-0.01	100.00
net debt to ebitda	-0.29	-0.61	53.23
current ratio	6.79	5.64	20.39
interest coverage	-323.03	280.14	-215.31
income quality	1.27	1.17	8.54
dividend yield	0.04	0.03	14.21
payout ratio	0.21	0.29	-28.45
sales general and administrative to revenue	0.14	0.08	70.69
research and ddevelopement to revenue	0	0.11	-100.00
intangibles to total assets	0.05	0.26	-81.62
capex to operating cash flow	0.54	0.63	-14.14
capex to revenue	0.27	0.27	0.02
capex to depreciation	23.68	2.18	985.82
stock based compensation to revenue	0	0.0	-100.00
graham number	50.87	39.56	28.60
roic	0.17	0.17	5.04
return on tangible assets	0.19	0.21	-6.63
graham net net	8.14	7.78	4.53
working capital	991641000	949612000	4.43
tangible asset value	2276994000	1434607000	58.72
net current asset value	952867000	913426000	4.32
invested capital	1301175000	1693661000	-23.17
average receivables	179405000	145291500	23.48
average payables	65477000	62749500	4.35
average inventory	8138500	14293500	-43.06
days sales outstanding	57.42	63.33	-9.34
days payables outstanding	56.43	107.89	-47.70
days of inventory on hand	3.43	19.0	-81.95
receivables turnover	6.36	5.76	10.31
payables turnover	6.47	3.38	91.21
inventory turnover	106.42	19.21	454.02
roe	0.2	0.17	17.27
capex per share	3.3	2.54	29.78

• Positive

  ROE: Return on Equity (ROE) increased to 0.20 on 2023-12-31 from 0.17 on 2022-12-31, representing a change of 17.27%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 5.89 on 2023-12-31 from 9.40 on 2022-12-31, representing a change of -37.35%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 6.79 on 2023-12-31 from 5.64 on 2022-12-31, representing a change of 20.39%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.00 on 2023-12-31 from -0.01 on 2022-12-31, representing a change of 100.00%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
OTGLY
calendar year	2024	2024	NaN
revenue per share	1.98	0.57	249.69
net income per share	0.7	0.25	179.93
operating cash flow per share	0.7	0.45	54.74
free cash flow per share	-0.1	0.29	-135.41
cash per share	4.9	2.62	87.40
book value per share	24.86	6.26	296.84
tangible book value per share	23.58	4.56	417.26
shareholders equity per share	24.86	6.26	296.84
interest debt per share	0.0	0.0	195.03
market cap	3431026827.68	11701934904.2	-70.68
enterprise value	3300674827.68	11596084904.2	-71.54
pe ratio	12.26	29.24	-58.05
price to sales ratio	17.33	51.6	-66.42
pocfratio	49.06	64.65	-24.12
pfcf ratio	-331.08	99.84	-431.63
pb ratio	1.38	4.67	-70.41
ptb ratio	1.38	4.67	-70.41
ev to sales	16.67	51.13	-67.40
enterprise value over ebitda	30.63	90.91	-66.30
ev to operating cash flow	47.2	64.07	-26.33
ev to free cash flow	-318.51	98.93	-421.94
earnings yield	0.02	0.01	138.40
free cash flow yield	-0.0	0.01	-130.15
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	-1.21	-0.83	-45.78
current ratio	8.12	6.94	16.99
interest coverage	193.2	196.37	-1.61
income quality	1.0	1.81	-44.72
dividend yield	0.03	0	NaN
payout ratio	1.43	0	NaN
sales general and administrative to revenue	0.13	0.15	-10.33
research and ddevelopement to revenue	0.13	0.09	40.22
intangibles to total assets	0.05	0.25	-80.88
capex to operating cash flow	1.15	0.35	225.81
capex to revenue	0.41	0.28	44.17
capex to depreciation	2.69	2.13	26.24
stock based compensation to revenue	0	0.02	-100.00
graham number	19.78	5.94	233.30
roic	0.02	0.03	-36.02
return on tangible assets	0.03	0.05	-43.67
graham net net	3.79	2.24	68.86
working capital	995085000	1071211000	-7.11
tangible asset value	2356947000	1824757000	29.16
net current asset value	959195000	1035397000	-7.36
invested capital	1340779000	1954559000	-31.40
average receivables	85981500	140777500	-38.92
average payables	59263000	59140000	0.21
average inventory	3289500	3418000	-3.76
days sales outstanding	38.14	34.94	9.18
days payables outstanding	84.68	86.22	-1.79
days of inventory on hand	4.76	4.73	0.61
receivables turnover	2.36	2.58	-8.41
payables turnover	1.06	1.04	1.82
inventory turnover	18.92	19.03	-0.60
roe	0.03	0.04	-29.46
capex per share	0.8	0.16	404.14

• Negative

  ROE: Return on Equity (ROE) decreased to 0.03 on 2024-06-30 Q2 from 0.04 on 2024-03-31 Q1, representing a change of -29.46%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 12.26 on 2024-06-30 Q2 from 29.24 on 2024-03-31 Q1, representing a change of -58.05%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 8.12 on 2024-06-30 Q2 from 6.94 on 2024-03-31 Q1, representing a change of 16.99%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None